Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus normal saline for postoperative infection after primary total knee arthroplasty
IRCT20260713070167N1Phase 3Recruiting
- Sponsor
- Islamic Azad University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in surgical site infection (SSI) and periprosthetic joint infection (PJI) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Incidence of periprosthetic joint infection following total knee arthroplasty. Started Sep 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
surgical site infection (SSI)periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on IRCT20260713070167N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260713070167N1.